QL
SNDX icon

Quarry LP’s Syndax Pharmaceuticals SNDX Stock Holding History

Quarry LP’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$210K – 2181
2025
Q4 		$210K Sell
10,000
-25,365
-72% -$443K 0.03% 264
2025
Q3 		$544K Sell
35,365
-23,635
-40% -$309K 0.12% 132
2025
Q2 		$553K Buy
59,000
+57,000
+2,850% +$627K 0.12% 141
2025
Q1 		$24.6K Buy
+2,000
New +$28.2K 0.01% 1061
2024
Q3 		– Sell
-6,125
Closed -$126K – 2049
2024
Q2 		$126K Buy
6,125
+2,625
+75% +$54.9K 0.04% 275
2024
Q1 		$83.3K Buy
3,500
+2,750
+367% +$61.3K 0.02% 275
2023
Q4 		$16.2K Buy
+750
New +$11.5K ﹤0.01% 868

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Quarry LP's SNDX Position: Q1 2026 in Review

Quarry LP sold out of Syndax Pharmaceuticals (SNDX) in Q1 2026, closing a stake of 10,000 shares — an estimated $210K sold.

Quarry LP first reported a position in SNDX in Q4 2023 and held it in 7 quarters. The position peaked at $553K in Q2 2025. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Quarry LP reported no remaining Syndax Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Quarry LP sold 10,000 Syndax Pharmaceuticals shares in Q1 2026, an estimated $210K.
  • Quarry LP first reported a position in Syndax Pharmaceuticals in Q4 2023 and held it in 7 quarters.
  • Quarry LP's Syndax Pharmaceuticals position peaked at $553K in Q2 2025.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.